CLL-1 expression percentage and MFIR do not exhibit any notable correlation with sex, age, hemoglobin level, total leukocyte count, platelet count, lactate dehydrogenase levels, lymphadenopathy, status of newly diagnosed untreated patients versus patients in relapse, or different cytogenetic prognostic factors in AML patients [30, 31]. This evidence concerns the gene CLEC12A and acute myeloid leukemia.